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Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized 
by the production of anti-nuclear antibodies. SLE is one of many autoimmune dis-
orders that have a strong gender bias, with 70–90% of SLE patients being female. 
Several explanations have been postulated to account for the severity of autoimmune 
diseases in females, including hormonal, microbiota, and gene dosage differences. 
X-linked toll-like receptors (TLRs) have recently been implicated in disease progression 
in females. Our previous studies using the 564Igi mouse model of SLE on a Tlr7 and 
Tlr9 double knockout background showed that the presence of Tlr8 on both X chro-
mosomes was required for the production of IgG autoantibodies, Ifn-I expression and 
granulopoiesis in females. Here, we show the results of our investigation into the role of 
Tlr8 expression in SLE pathogenesis in 564Igi females. Female mice have an increase 
in serum pathogenic anti-RNA IgG2a and IgG2b autoantibodies. 564Igi mice have also 
been shown to have an increase in neutrophils in vivo, which are major contributors 
to Ifn-α expression. Here, we show that neutrophils from C57BL/6 mice express Ifn-α 
in response to 564 immune complexes and TLR8 activation. Bone marrow-derived 
macrophages from 564Igi females have a significant increase in Tlr8 expression com-
pared to male-derived cells, and RNA fluorescence in situ hybridization data suggest 
that Tlr8 may escape X-inactivation in female-derived macrophages. These results 
propose a model by which females may be more susceptible to SLE pathogenesis due 
to inefficient inactivation of Tlr8.
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introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the produc-
tion of anti-nuclear antibodies (1). Like many other autoimmune disorders, SLE is more prevalent 
in females, with 70–90% of SLE patients being female (2). The basis for the gender bias in SLE and 
other autoimmune diseases is poorly understood. Hormonal differences, changes in microbiota, and 
X-linked gene dosage are all being investigated as potential driving factors.
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Autoantibodies mediate many of the pathologies associated 
with SLE by forming immune complexes (IC) and depositing in 
various tissues, promoting tissue damage. It has been shown that 
autoantibodies also cause developmental defects in the offspring 
born to female SLE patients (3). Female patients have been 
shown to have an increase in miscarriages during pregnancy (4, 
5). Furthermore, offspring born to female SLE patients have an 
increased incidence of cognitive disorders compared to healthy 
controls (6–11). It has been reported that certain maternal anti-
DNA antibodies are able to cross the placenta during pregnancy 
and cause neuronal excitotoxicity in female offspring (7, 12–14). 
These antibodies cross-react with a fetal neuronal glutamate 
receptor that has differential timing of expression in male and 
female embryos, which accounts for the preferential female fetal 
death (14). Fully understanding the cause of the female bias of 
SLE is critical to preventing the production of such pathogenic 
antibodies.
Several immune-linked genes are located on the X chromo-
some and have been implicated in SLE pathogenesis, including 
endosomal toll-like receptors (TLRs) 7 and 8 (15). Endosomal 
TLRs 7, 8, and 9 are intracellular nucleic acid sensors that play 
varying roles in the development of SLE. TLR9 contributes to the 
production anti-DNA antibodies (16), but it was also revealed 
to act as a negative regulator of disease pathogenesis (17–19). 
TLR7 is largely thought to promote anti-RNA autoantibody 
production (20–25). However, Tlr7-deficiency in mice does not 
completely eliminate anti-nuclear antibody production (22, 24). 
It was recently reported that a deficiency of both Tlr7 and Tlr8 
is required to eliminate anti-nuclear antibody production (15), 
suggesting that TLR8 is a significant contributor. TLR8 can also 
induce granulopoiesis in the bone marrow and Ifn-I expression 
in neutrophils in female mice (15). Human SLE patients have 
increased circulating granulocytes and increased IFN-I produc-
tion (26, 27). IFN-I signaling is known to be involved in the 
development of SLE-like symptoms (28, 29).
Interestingly, SLE-like pathology, including autoantibody pro-
duction, increased granulopoiesis and increased Ifn-I expression, 
are alleviated in female mice deficient in one copy of X-linked 
Tlr8 (15). The phenotype of these females closely resembles that 
of their male counterparts, suggesting that gene dosage, not 
hormonal influences, may contribute the female bias of SLE. 
To investigate the role of TLR8 in SLE pathogenesis, we use the 
564Igi mouse model of SLE. 564Igi mice have knock-in genes at 
the immunoglobulin (Ig) heavy (H) and light (L) chain loci that 
encode for an anti-RNA antibody. These mice develop SLE-like 
symptoms, including autoantibodies, increased granulopoiesis, 
increased IFN-I production, and glomerulonephritis (20). There 
is also a female bias in this mouse model, closely resembling 
human disease. 564Igi mice were found to have an increase in 
monocyte and neutrophil populations, both of which contribute 
to the increased IFN-I production (30). Recognition of IFN-I by 
neutrophils leads to the upregulation of FcγRIV (30). FcγRIV is 
the activating Fc receptor for IgG2a and IgG2b IC. The ratio of 
FcγRIV to FcγRIIb, the inhibitory receptor for IgG2a and IgG2b 
IC, determines the threshold of activation for the cell by IgG 
antibodies. A shift in the ratio of the receptors can make the cell 
more or less sensitive to activating stimuli. Thus, in 564Igi mice, 
expanded neutrophil and monocyte populations produce IFN-I 
and increase the FcγRIV:FcγRIIb ratio in neutrophils, which may 
make cells more susceptible to activation by IC. One potential 
mechanism to induce granulopoiesis in 564Igi mice is through 
the production of autoantibodies, which could be the initiating 
factor in neutrophil activation. However, autoantibody produc-
tion is not sufficient for either granulopoiesis or Ifn-I expression 
in 564Igi mice (15). Therefore, an alternative mechanism must 
exist to promote the expansion of neutrophils, Ifn-I expression, 
and autoantibody production. Autoantibody production in 
564Igi mice is known to depend on TLR7 and TLR8 (15, 20), 
and expression of Tlr8 on both X chromosomes is necessary to 
promote SLE-like symptoms in 564Igi mice (15). Furthermore, 
SLE-like symptoms in 564Igi mice have a female bias. Therefore, 
we sought to examine the role of TLR8 in SLE pathogenesis.
Here, we show that female mice have elevated levels of patho-
genic IgG autoantibodies and that Ifn expression in neutrophils 
is mediated by immune complex formation and TLR8 activation. 
Female mice also have significantly increased Tlr8 expression in 
bone marrow-derived macrophages (BMDM), which is likely 
due to escape of X-inactivation. These results describe a novel 
mechanism of SLE pathogenesis specific for females through 
inefficient X-inactivation of X-linked TLR8.
Materials and Methods
Mice
All experiments with mice were performed in accordance with 
the regulations of and with the approval off the Tufts/TMC 
IACUC (protocol B2012-50). Creation of the 564Igi mice was 
previously described (20) and they were bred in house. All 564Igi 
mice are homozygous for both the IgH and IgL knock-in genes 
unless otherwise indicated. C57BL/6 and FcγRIIb−/− mice were 
purchased from Jackson Laboratories. Tlr8−/− mice were gener-
ously gifted by Dr. D. Golenbock and Dr. R. Gazzinelli at the 
University of Massachusetts Medical School, Worcester, MA, 
USA with the permission of Dr. R. Flavell at Yale University, New 
Haven, CT, USA.
anti-rna/Dna elisas
Nunc MaxiSorb flat-bottom ELISA plates (ThermoFisher 
442404) were coated with 0.1% w/v poly-l-lysine solution 
(Sigma P8920) for 4 h at room temperature for anti-RNA ELISA 
or 1% protamine sulfate diluted in PBS for 30 min at room tem-
perature for anti-DNA ELISA. The solution was then removed 
and 50 μg/mL of yeast RNA (Ambion AM7120G) or calf-thymus 
DNA (Invitrogen) diluted in 1× borate buffer (100  mM boric 
acid, 25  mM sodium borate, 75  mM sodium chloride) was 
added and incubated at 4°C overnight. Plates were washed 3× in 
0.1%Tween/borate and then blocked with 5% goat serum/0.05% 
Tween/0.1% sodium azide/borate for anti-RNA ELISA or 1% 
BSA/0.1% sodium azide/borate for anti-DNA ELISA for 2 h at 
room temperature. Plates were washed 3× in 0.1% Tween/borate 
and then serum samples or cell culture supernatants were added 
using serial dilutions in blocking buffer and incubated at 4°C 
overnight. Plates were washed 3× in 0.1% Tween/borate and 
antibodies were detected with 1  μg/mL alkaline phosphatase 
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(AP)-conjugated goat-anti-mouse IgG2a/IgG2b antibodies 
(Southern Biotech) diluted in blocking buffer. Plates were 
washed 5× in 0.1% Tween/borate and developed with 1 mg/mL 
AP substrate p-nitrophenyl phosphate (Life Technologies) 
diluted in ELISA buffer (0.1  M glycine, 1  mM zinc chloride, 
1 mM magnesium chloride). The optical density (O.D.) was read 
at 405 nm.
Flow cytometry
Cells were stained for flow cytometry according to standard 
procedures (20). Neutrophils were stained with anti-CD11b-
Alexa488 and anti-Ly6C-PE or anti-Ly6G-PE (Biolegend). 
Macrophages were stained with anti-F4/80-Alexa647 (Biolegend). 
Fluorescently labeled antibodies were generally used at 1 μg/mL.
cell culture
Purified neutrophils were sorted by flow cytometry and cultured 
in 10% FCS RPMI media supplemented with penicillin/strepto-
mycin, l-glutamine, 2-mercaptoethanol, amphotericin, sodium 
pyruvate, and non-essential amino acids for 16 h in the presence 
of CLO75 (1 mg/mL), CLO97 (1 mg/mL), or 4 h in the presence of 
purified 564 immune complex (0.01 μg/mL). BMDM were grown 
by culturing whole bone marrow cell suspensions in 20% FCS 
RPMI media supplemented with penicillin/streptomycin and 
25% L cell line culture supernatant for 7 days.
Quantitative real-Time Pcr
RNA was isolated from cells by TRIzol incubation (Life 
Technologies 15596) followed by chloroform extraction. All 
quantitative real-time PCR (RT-qPCR) experiments were per-
formed using two serial dilutions of RNA and iScript Reverse 
Transcription Supermix for RT-qPCR from Bio-Rad (170-8841). 
Triplicate cDNA samples were used for the amplification of 
β-actin, Ifn-α6, Tlr7, and Tlr8 using commercially available FAM 
primer probes (Life Technologies) and a Bio-Rad IQ5 quantita-
tive PCR system. Gene expression was normalized to β-actin 
expression based on a standard curve.
rna Fluorescence in Situ hybridization
Bone marrow-derived macrophages were cultured as described 
above and sent to Biosearch Technologies, Petaluma, CA, USA. 
Stellaris® RNA fluorescence in  situ hybridization (FISH) was 
performed as recommended by the manufacturer and described 
in (31).
All probe sets were manufactured by Biosearch and labeled 
as follows: Xist, Quasar® 670; Eif2s3x introns, Quasar 570; Tlr7 
exons, CalFluor Red 610, Tlr7 introns, Quasar 570; Tlr8 exons, 
Quasar 570. Tlr8 introns, CalFluor Red 610. Cells fixed and 
hybridized with combinations of probe sets were imaged on a 
widefield Nikon fluorescence microscope and images with spe-
cific RNA signals were processed in FIJI (Image J).
statistical analysis
The p values were calculated using one-way ANOVA for all 
analyses, followed by the Tukey multiple comparison test (Prism 
GraphPad Software). For all figures, *p  <  0.05, **p  <  0.01, 
***p < 0.001.
results
Female Mice have increased Pathogenic  
anti-rna igg autoantibodies compared 
to Males
The production of autoantibodies is the characteristic symptom 
of SLE and mediates many of the pathologies associated with dis-
ease. To begin investigating the gender bias of SLE in 564Igi mice, 
we measured the RNA reactivity of serum antibodies in male and 
female mice. Female 564Igi mice have significantly more anti-
RNA IgG2a antibodies than male 564Igi mice (Figure 1A).
It has been reported that certain maternal anti-nucleic acid 
antibodies can cause preferential female fetal loss by neuronal 
excitotoxicity (7, 12–14). To examine the effect of the 564 anti-
body on fetal development, we counted the number of live male 
and female offspring born to mothers with various genotypes. 
C57BL/6 females yield litters with approximately 1:1 ratio of 
males:females when bred to 564Igi males (Figure 1B, blue), sug-
gesting that 564Igi males have little effect on fetal development. 
564Igi females, on the other hand, yield litters with an elevated 
male:female ratio when bred to C57BL/6 males (Figure 1B, pink). 
564Igi females are poor breeders that often take far longer to get 
pregnant than C57BL/6 females and often give birth to still-born 
offspring. In addition, 564Igi females are more likely to suffer 
from dystocia during pregnancy compared to C57BL/6 females. 
As a result, we have few data points from 564Igi females and no 
conclusive data from 564Igi females bred to 564Igi males. 564Igi 
females heterozygous for the 564 IgH and IgL knock-ins (564Igi±) 
also yield litters with elevated male:female ratios (Figure  1B, 
black), although there is more variability across litters.
To validate that the 564 antibody itself is mediating patho-
genesis, we transfected HEK293T cells with DNA encoding the 
unmutated 564 antibody or mutated variants (Clone M and 
Clone O). Culture supernatant containing 1.5 μg of antibody or 
an equivalent volume of supernatant from an untransfected cell 
culture (Media) was then injected into C57BL/6 pregnant females. 
An equivalent amount of purified 2C10 anti-DNA antibody was 
also injected. We then counted the number of male and female 
offspring in each litter. The 564 antibody caused an increase in 
the ratio of males:females in each litter compared to the media 
control injection (Figure 1C, red). Clone M, Clone O, and 2C10 
had no effect on the number of female offspring (Figure  1C, 
purple, green, and blue). The RNA and DNA reactivity of the 
injected antibodies was determined by ELISA (Figures  1D,E). 
The 2C10 antibody shows reactivity to both DNA and RNA by 
ELISA, however, reactivity toward DNA is much stronger. The 
artificial nature of the ELISAs performed here may cause some 
degree of cross-reactivity among anti-nucleic acid antibodies. 
HEp-2 staining clearly distinguishes 2C10 as a DNA-specific 
antibody and 564 as an RNA-specific antibody (20) (Figure 1F).
A subset of anti-DNA antibodies have been reported to cause 
preferential female fetal loss, as measured by similar procedures 
(12, 14). However, the 2C10 antibody clearly has no effect on 
the number of male and female offspring born in each litter, and 
therefore is unlikely to be considered in those classes of anti-DNA 
antibodies. Clone O shows reduced anti-RNA reactivity com-
pared to the 564 antibody (Figure 1D), which may explain the 
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normal ratio of males:females born to dams injected with Clone 
O. Interestingly, dams injected with Clone M also yielded litters 
with normal male:female ratios even though the RNA reactivity 
of Clone M is equivalent to that of the 564 antibody (Figure 1D). 
The mutations in Clone M may not affect RNA reactivity, but may 
affect antibody reactivity to neuronal receptors in vivo, resulting 
in normal litters despite RNA reactivity. Together, these data 
reflect the increased prevalence of miscarriages among female 
SLE patients and also implicate some anti-RNA antibodies as 
contributors to pathogenesis in females.
564 immune complexes induce neutrophils to 
expand and express Ifn-α6
564Igi mice were shown to have significantly more monocytes and 
neutrophils compared to C57BL/6 controls (30). To determine 
if the 564 antibody plays a role in the increase in granulocytes, 
we injected normal C57BL/6 mice with the 564 antibody and 
then whole bone marrow cell suspensions were analyzed for the 
presence of neutrophils 2 weeks later. The 564 antibody induced 
a significant increase in the percent of neutrophils in the bone 
FigUre 1 | 564igi females have more circulating pathogenic igg autoantibodies. (a) Anti-RNA antibodies were detected using and isotype-specific 
anti-RNA ELISA. Shown is the mean O.D. 405 nm ± SEM at various serum dilutions. The number of mice is shown in the key. (B) Shown is the ratio of male:female 
offspring born to the dam in the indicated breeding pair. Each data point represents a single litter. The average ratio is shown with a horizontal line. (c) Pregnant 
C57BL/6 dams were given introperitoneal injections with 1.5 μg of the indicated antibody or media control at approximately embryonic days 13–15. Shown is the 
ratio of male:female offspring in each litter. Each data point represents a single litter. The average ratio is shown with a horizontal line. (D,e) The mean (D) anti-RNA 
and (e) anti-DNA reactivities of the indicated antibodies were tested by ELISA. Shown is the mean O.D. 405 nm ± SEM at the indicated antibody concentrations. 
The number of replicates is shown in the key. (F) Purified 564 and 2C10 antibodies were tested for anti-nuclear reactivity by HEp-2 staining. Shown are the staining 
representative staining patterns of at least four independent experiments.
marrow compared to a control saline injection and an isotype 
control (Figure 2A).
Both neutrophils and monocytes in 564Igi mice make sig-
nificant contributions to IFN-I production (30). IFN-I signaling 
causes an upregulation of FcγRIV in 564Igi neutrophils, the acti-
vating receptor for IgG2a and IgG2b IC (30). The ratio of FcγRIV 
to FcγRIIb, the inhibitory receptor, sets the activation threshold 
for the response to IC (32). To test the neutrophil response to 
564 IC, purified neutrophils from C57BL/6 mice (Figure  2B) 
were cultured in vitro in the presence of purified 564 antibody 
or 564 IC and Ifn-α6 expression was measured by RT-qPCR. 
Previous studies have used Ifn-α6 to study the role of endosomal 
TLRs in IFN-I production (15, 33). The 564 IC slightly increased 
Ifn-α6 expression compared to untreated cells in C57BL/6 mice 
(Figure  2C, green), showing that the 564 antibodies in 564Igi 
mice may activate neutrophils. Furthermore, neutrophils from 
FcγRIIb−/− mice, which lack the inhibitory Fcγ receptor for IgG2b 
IC, show a significant increase in Ifn-α6 expression (Figure 2C, 
blue), similar to the increased Ifn-α6 expression in neutrophils 
that have upregulated FcγRIV (30). This suggests that altering the 
FigUre 2 | 564 igg2b ic activates neutrophils to express Ifn-α6.  
(a) C57BL/6 mice were given intraperitoneal injections with 40 μg of 564 
antibody, an isotype control of unknown specificity or a comparable volume of 
saline control. Two weeks later, the number of neutrophils in the bone marrow 
was determined by flow cytometry. Shown is the percent of neutrophils in 
each mouse. The average is shown as a horizontal line. (B) Neutrophils were 
purified from whole bone marrow cell suspensions from the indicated mice by 
cell sorting (CD11b+ Ly6G+). Shown is a representative plot of the gate used to 
purify neutrophils. (c) Purified neutrophils were cultured for 4 h in the presence 
of 0.01 μg/mL purified IgG2b 564 antibody or 564 IC made by incubating 
purified IgG2b 564 antibody with bone marrow-derived RNA. RNA was 
extracted from the cell culture, converted to cDNA, and Ifn-α6 expression was 
measured by RT-qPCR. Expression was normalized to β-actin and compared 
to untreated samples from each genotype. Shown is the average ± SEM 
fold-increase in Ifn-α6 expression in three mice per group tested in 
independent experiments, each done in triplicate.
FigUre 3 | Tlr8 agonist induces increased Ifn-α6 expression in 
neutrophils. Neutrophils were purified from whole bone marrow cell 
suspensions from the indicated mice by cell sorting as in Figure 2B. 
Neutrophils were cultured for 16 h in the presence of the TLR8 agonist 
CLO75 (1 mg/mL) or the TLR7 agonist CLO97 (1 mg/mL). RNA was 
extracted from the cell culture, converted to cDNA, and Ifn-α6 transcript level 
was measured by RT-qPCR. Expression was normalized to β-actin and 
compared to untreated samples from each genotype. Shown is the 
average ± SEM fold-increase in Ifn-α6 expression in two mice per group 
tested in independent experiments, each done in triplicate.
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ratios of Fcγ receptors can change the sensitivity of neutrophils 
to IC. 564 IC did not have any effect on the expression of Tlr7 
and Tlr8 in either C57BL/6 or FcγRIIb−/− neutrophils (data not 
shown). Purified 564 antibody also induced moderate Ifn-α6 
expression in FcγRIIb−/− neutrophils, likely due to the formation 
of IC in  vivo after injection and the hyper-responsiveness of 
neutrophils from FcγRIIb−/− mice.
Tlr8 agonist induces Ifn-α6 expression in 
neutrophils
To examine the role of Tlr8 expression in IFNα production in 
neutrophils, we cultured purified neutrophils from C57BL/6 
mice in the presence of the TLR8 agonist CLO75 or the TLR7 
agonist CLO97 and measured Ifn-α6 expression. Neutrophils 
from C57BL/6 mice treated with both CLO75 and CLO97 had 
increased Ifn-α6 expression. However, CLO75 increased Ifn-α6 
significantly more than CLO97 (Figure  3, green). Neutrophils 
from Tlr8-deficient mice responded poorly to both CLO75 and 
CLO97 (Figure 3, blue). Tlr7 expression is significantly decreased 
in Tlr8-deficient neutrophils (15), which may explain the poor 
response of Tlr8-deficient cells to a TLR7 agonist. Still, these 
data show that activation of TLR8 induces Ifn-α6 expression in 
neutrophils.
Bone Marrow-Derived Macrophages from 
Female Mice Over-express Tlr8, Possibly 
Through inefficient X-inactivation
As described above, 564Igi females have increased IgG autoan-
tibodies compared to males (Figures  1A,B). Autoantibody 
production in 564Igi mice is mediated by TLR7 and TLR8 (15, 
20). Therefore, the increase in pathogenic IgG autoantibodies 
in 564Igi females may be the result of differential expression of 
X-linked Tlr7 and/or Tlr8. To examine the expression of Tlr7 
and Tlr8, we used RT-qPCR and RNA FISH. Neutrophils were 
not used in these experiments because neutrophils did not sur-
vive the culturing process necessary for RNA-FISH. However, 
we have previously shown that neutrophils from 564Igi mice 
over-express Tlr7 and Tlr8 compared to C57BL/6 mice at both 
the mRNA and protein level (15). Here, we use BMDM from 
male and female C57BL/6 and 564Igi mice because monocytes 
and macrophages were also shown to produce IFN-I in 564Igi 
FigUre 4 | BMDM from 564igi females have increased transcript levels of Ifn-α6, Tlr7, and Tlr8 compared to BMDM from male 564igi mice. (a) Whole 
bone marrow cell suspensions from female and male mice were grown in cell culture media to select for the growth of macrophages (20% FCS, 25% L-292 cell 
culture supernatant, 10 U/mL penicillin/streptomycin, RPMI). Shown is a representative plot showing the percentage of neutrophils, monocytes, and macrophages 
after culturing compared to whole bone marrow and RAW 264.7 macrophage cell line. (B–D) After 7 days in culture, RNA was isolated from the cells, converted to 
cDNA, and (B) Ifn-α6, (c) Tlr7, and (D) Tlr8 expression was measured by RT-qPCR. Expression was normalized to β-actin and compared to Ifn-α6, Tlr7, and Tlr8 
expression in the RAW 264.7 macrophage cell line. Shown is the average ± SEM fold-increase in expression two mice per group, tested in two independent 
experiments, each done in triplicate.
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mice (30). BMDM were cultured from whole bone marrow 
cell suspensions and analyzed by flow cytometry for pheno-
typic similarity to the RAW264.7 mouse macrophage cell line 
(Figure 4A). RAW264.7 was subsequently used for normaliza-
tion in qRT-PCR analyses. BMDM from both C57BL/6 and 
564Igi male and female mice express Ifn-α6 (Figure 4B), similar 
to the primary neutrophils and monocytes/macrophages found 
in 564Igi mice (30). However, BMDM from female 564Igi mice 
express significantly more Ifn-α6 than BMDM from male 564Igi 
mice and C57BL/6 female mice, suggesting that BMDM may 
significantly contribute to IFN-I production in  vivo. The phe-
notypic similarities between BMDM and primary neutrophils/
macrophages from 564Igi mice support our use of these cells in 
subsequent experiments. BMDM from female 564Igi mice also 
over-express Tlr7 and Tlr8 compared to male 564Igi-derived 
and C57BL/6-derived BMDM (Figures  4C,D). These results 
are similar to what has been published for primary neutrophils 
from 564Igi mice, which over-express Tlr7 and Tlr8 compared to 
neutrophils from C57BL/6 mice by both qRT-PCR and Western 
blot (15). Furthermore, the fold-increase in Tlr8 expression in 
female BMDM is several orders of magnitude higher than the 
fold-increase in Tlr7 expression. Although both Tlr7 and Tlr8 are 
located on the X chromosome, it appears that Tlr8 may be more 
significantly dysregulated than Tlr7 and may play a larger role in 
facilitating SLE pathogenesis in females.
It has been shown that 564Igi females with two normal copies 
of Tlr8, one on each X chromosome, express Tlr8 approximately 
twofold higher than 564Igi females carrying only one copy 
of Tlr8 (15). These data led to the hypothesis that inefficient 
X-inactivation may be responsible for the significant increase in 
Tlr8 expression in female BMDM. To examine this possibility, we 
used RNA-FISH to detect the presence of Tlr7 and Tlr8 exonic 
mature mRNA in BMDM from C57BL/6 males and females. In 
female BMDM, there appears to be more Tlr8 transcript than in 
male BMDM (Figure  5A), consistent with the RT-qPCR data 
(Figures 4C,D).
To determine if the increase in Tlr8 expression is due to 
escaped X-inactivation, we used RNA-FISH to detect Tlr7 
FigUre 5 | Tlr8 rna co-localizes with Xist rna. (a–F) BMDM from C57BL/6 and 564Igi mice were stained for the presence of Xist and (a) Tlr7 and Tlr8 exonic 
mRNA, (B) Eif2s3x intronic mRNA, (c) Tlr7 intronic and exonic mRNA or (D–F) Tlr8 intronic and exonic mRNA using fluorescent probes. (a) An example of 
increased Tlr8 mRNA compared to Tlr7 mRNA in female BMDM. (B) Two examples of escaped X-inactivation of Eif2s3x. (c) An example of normal X-inactivation of 
Tlr7. (D) An example of potential escaped X-inactivation of Tlr8 in C57BL/6 female BMDM. (e) An example of potential escaped X-inactivation of Tlr8 in 564Igi 
female BMDM. 1/800 cells (~0.1%) show this staining pattern. The insert shows the Xist-cloud with the Tlr8 and weak Eif2s3x signals. (F) An example of normal 
X-inactivation of Tlr8 in C57BL/6 female BMDM. The probes used in each set of images are shown underneath. Intronic (int) probes detect nuclear pre-mRNA 
before splicing. Exonic (ex) probes also detect cytoplasmic mature mRNA after splicing. White arrowheads show target RNA expression from active X chromosome. 
White arrows show target RNA expression from inactivated X chromosome.
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and Tlr8 immature intronic mRNA transcripts and Xist RNA, 
the long non-coding RNA required for X-inactivation (34) in 
C57BL/6 and 564Igi female BMDM. Co-localization of target 
intronic RNA and Xist RNA suggests that the gene is being 
expressed from the inactive X chromosome. Eif2s3x, a known 
essential gene with a high X-inactivation escape frequency (35), 
was used as a positive control (Figure 5B, top and bottom). We 
did not detect any cells with Tlr7 intronic RNA and Xist RNA 
co-localized, suggesting that Tlr7 is appropriately silenced on the 
inactivated X chromosome (Figure 5C), consistent with previ-
ous reports (36). However, there were some cells that showed 
Tlr8 intronic RNA at two locations in the nuclei in both C57BL/6 
and 564Igi BMDM: isolated from Xist RNA and co-localized 
with Xist RNA (Figures  5D,E), suggesting that Tlr8 is being 
expressed from both the active and inactive X chromosomes 
in some cells. The transcription burst events for Eif2s3x and 
Tlr8 seem uncoupled as we note expression from either or both 
alleles for both genes in some cells. In other cells, however, we 
capture the events for both alleles for both genes, with the burst 
from the inactive X chromosome located at the fringe of the 
Xist-cloud. Cells that showed co-localization of Tlr8 and Xist, 
and hence Tlr8 expression from both X chromosomes, also had 
more mature, exonic Tlr8 mRNA transcript compared to cells 
that expressed a single copy of Tlr8 (Figures 5D–F). Our data 
therefore are consistent with that Tlr8 escapes X-inactivation 
in some macrophages, contributing to its higher expression in 
female-derived cells.
Our data suggest a model of SLE pathogenesis specific to 
females where Tlr8 escapes X-inactivation, and, as a result, is 
over-expressed. Activation of TLR8 leads to Ifn-a6 production in 
neutrophils. IFN-I can activate developing B cells (30) to promote 
the production of autoantibodies. The increased autoantibodies 
in circulation in female mice can then form IC that activate 
neutrophils and propagate the production of IFN-I and SLE 
pathogenesis.
Discussion
Systemic lupus erythematosus has a strong gender bias with a 9:1 
ratio of female:male patients. The mechanisms responsible for 
the female preference are unclear and may involve a combination 
of genetic and environmental factors. Here, we show that Tlr8 
escape of X-inactivation may be a driving factor for the increased 
incidence of SLE among female mice.
In addition to the pathogenic effects autoantibodies are 
known to exert in SLE patients, previous studies have shown 
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that maternal autoantibodies are able to mediate developmental 
defects in offspring born to female SLE patients (3). Here, we 
show that female 564Igi mice have an increase in serum anti-RNA 
IgG2a and IgG2b antibodies (Figure 1A). Pregnant 564Igi female 
mice also yield litters with few females (Figure 1B), which seems 
to be a direct effect of circulating 564 antibodies (Figure  1C). 
IgG antibodies are able to cross the placenta during pregnancy 
and surpass maternal circulation levels in the newborn (37). In 
particular, neurological defects are common in offspring born 
to SLE mothers (6–11, 38). Although the blood–brain bar-
rier prevents antibody access to the adult brain, the immature 
blood–brain barrier in developing embryos allows antibodies 
to enter the developing brain (37). Studies have confirmed that 
some classes of anti-DNA antibodies are able to react with fetal 
neuronal receptors and cause neuronal death via excitotoxicity 
and female fetal death (7, 12–14). The receptor is expressed at 
different times during development in male and female embryos, 
which may explain why the defect is largely seen in only female 
offspring (14). The 564 antibody also reacts with a consensus 
peptide sequence of the neuronal receptor (data not shown). 
Therefore, circulating 564 antibodies in 564Igi female mice may 
mediate female fetal death by a similar mechanism. Furthermore, 
these data show that anti-RNA antibodies, not only anti-DNA 
antibodies, are pathogenic to developing offspring.
We have previously shown that Ifn-α6 expression in neutrophils 
of 564Igi mice is dependent on TLR8 in vivo (15). Those results 
are confirmed here in C57BL/6-derived cells in  vitro showing 
that cells treated with a TLR8 agonist induce Ifn-α6 expression 
(Figure 3). In addition, IFN-I signaling in 564Igi mice upregu-
lates FcγRIV expression in neutrophils (30), which may lower 
the activation threshold by increasing the FcγRIV:FcγRIIb ratio. 
Here, we directly show that 564 antibodies cause an expansion of 
neutrophil populations (Figure  2A) and induce neutrophils to 
express Ifn-α6 (Figure 2C, green). Furthermore, the absence of 
FcγRIIb dramatically increases Ifn-α6 expression, presumably by 
infinitely increasing the FcγRIV:FcγRIIb ratio (Figure 2C, blue). 
IFN-I has been shown to activate immature B cells in the bone 
marrow of 564Igi mice (30). Additionally, IgG autoantibodies in 
564Igi mice are known to be the result of CSR during early B cell 
development in the bone marrow (39). Thus, the self-reactive B 
cells in the bone marrow of 564Igi females may be stimulated 
with more IFN-I and produce more anti-RNA IgG2a and IgG2b 
antibodies. These antibodies may then feedback as IC to activate 
more neutrophils, whose activation threshold may have been 
lowered due to the increased FcγRIV:FcγRIIb ratio, further pro-
moting IFN-I production, and ultimately disease pathogenesis.
Previous studies using the 564Igi mouse model of SLE on a 
Tlr7/9−/− background show that gene dosage of X-linked Tlr8 
plays a significant role in disease pathogenesis. Female 564Igi 
Tlr7/9−/− mice with two normal X chromosomes, and hence 
two functional copies of Tlr8, produce autoantibodies, express 
Ifn-I in neutrophils, have expanded populations of granulocytes, 
and ultimately develop glomerulonephritis (15). Male 564Igi 
Tlr7/9−/− mice, on the other hand, only have one X chromosome 
and, therefore, only one copy of Tlr8. Male mice do not produce 
autoantibodies, have low expression of Ifn-I in neutrophils and 
fewer granulocytes than female mice (15). To distinguish between 
hormonal differences and gene dosage effects as potential causes 
for the differences between male and female phenotypes, female 
564Igi Tlr7/9−/− mice were generated with one X chromosome 
lacking Tlr8. These female mice were genetically similar to their 
male counterparts in that they expressed only one copy of Tlr8 
while retaining normal female hormone levels. Autoantibody 
production, Ifn-I expression and granulopoiesis were all dimin-
ished in 564Igi Tlr7/9−/− females with only one copy of Tlr8 (15). 
These results suggest that differences in gene dosage of Tlr8, not 
hormonal differences, are responsible for the SLE-like phenotype 
in 564Igi Tlr7/9−/− females.
To more closely examine the mechanisms of Tlr8 expres-
sion in female mice, we analyzed the level of X-inactivation of 
both Tlr7 and Tlr8 in C57BL/6 and 564Igi female BMDM. Tlr8 
intronic mRNA can be found in two locations in the nuclei of 
some BMDM: isolated from Xist RNA and co-localized with 
Xist RNA (Figures  5D,E), suggesting that Tlr8 is expressed 
from both the active and the inactivated X chromosomes. At 
least 15% of human genes consistently escape X-inactivation, 
with an additional 10% of genes escaping X-inactivation in a 
tissue- or cell-specific manner (40). These genes largely cluster 
to the distal portion of the X chromosome short arm (Xp) (40). 
Tlr7 and Tlr8 are also located at the distal end of Xp. One model 
of X-inactivation spreading proposes that long interspersed 
repeat elements (L1) serve as cis-acting elements to promote 
inactivation (41). L1 concentrations are inversely correlated with 
the proportion of genes that escape inactivation along the chro-
mosome; the most distal portion of Xp has the most genes that 
escape activation and the lowest concentration of L1 (40, 42). 
This provides a mechanism by which Tlr8 may inappropriately 
escape X-inactivation: although both Tlr7 and Tlr8 are located 
at the distal end of Xp, Tlr7 may be in close proximity to an L1 
element, ensuring its appropriate inactivation. Tlr8, on the other 
hand, may be further from an L1 element, allowing its escape 
from X-inactivation in some cells.
Toll-like receptor 8, like TLR7, is an intracellular sensor of 
single-stranded RNA. Under normal circumstances, TLRs do 
not recognize self nucleic acids. However, it has been shown that 
self-RNA or -DNA can trigger cell activation when transported 
to TLR-containing endosomes (43–45). Endogenous retroviral 
nucleic acid products have also been implicated in SLE by 
activation of TLRs. High concentrations of retroviral envelope 
glycoprotein gp70 have been found in the sera of (NZB x NZW)
F1, MRL, and BXSB lupus-prone mouse models upon immune 
activation (46). However, there have been few studies analyzing 
the expression of endogenous retroviral products between males 
and females in SLE. Anti-gp70 immune responses depend on 
TLR7, suggesting that the recognition of retroviral RNA initiates 
the response (24, 47). Unlike TLR7, little is known about murine 
TLR8 because, until recently, it was believed to be non-functional. 
Therefore, TLR8 may also play a role in the induction of immune 
responses to retroviral RNA. The upregulation of Tlr8 in BMDM 
from female 564Igi mice (Figure 4D) may make cells more sensi-
tive to endogenous RNA products and induce cells to express 
Ifn-I. An alternate explanation is that female mice express more 
retroviral RNA, stimulating a more robust TLR8 response due to 
its higher expression.
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There is a long history of endosomal TLR involvement in 
autoimmune disease. Studies of TLR7, 8, and 9 generally used 
universal knockout models, so the specific roles of these TLRs 
in B cells and myeloid cells remain unclear. Recent studies have 
shown that the protective and pathogenic effects of TLR9 and 
TLR7, respectively, on systemic inflammation are due to B 
cell-intrinsic effects (48, 49). One model used in those studies 
resulted in 20% of myeloid cells also being deficient for TLR7 
or TLR9 (48). Whether the small population of TLR-deficient 
myeloid cells contributed to the phenotype of the mice remains 
unknown. However, it seems clear that spontaneous germinal 
center formation requires B cell-intrinsic Tlr7 expression and 
is negatively regulated by B cell-intrinsic Tlr9 expression (49). 
Here, we show that TLR8, which has not been examined in a 
B cell-specific manner, may escape X-inactivate in myeloid cells 
and contribute to the elevated IFN-I production and systemic 
inflammation seen in the 564Igi mouse model of SLE. The precise 
roles of endosomal TLRs in autoimmune disease are still being 
investigated and, dissecting the differences between lymphoid- 
and myeloid-intrinsic factors will be critical to understanding 
these roles.
Collectively, our data show that inefficient X-inactivation of Tlr8 
in female mice may contribute to the significant gender bias of SLE. 
The resulting increase in Tlr8 expression then facilitates down-
stream pathologies, including IFN-I production by neutrophils and 
autoantibody production, ultimately creating a positive feedback 
loop to propagate IFN-I production and disease pathogenesis.
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